Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
Thrombosis Research
|
July 11, 2018
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells
Rocco Romagnuolo, Kristen DeMarco, Corey A Scipione, et al.
British Journal of Haematology
|
June 27, 2007
Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter
Mathieu Garand, Nazareth Bastajian, Michael E Nesheim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2022
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion
Amer Youssef, Justin R Clark, Santica M Marcovina, et al.
Progress in Lipid Research
|
September 11, 2017
The renaissance of lipoprotein(a): Brave new world for preventive cardiology?
Katrina L Ellis, Michael B Boffa, Amirhossein Sahebkar, et al.
Atherosclerosis
|
June 1, 2018
Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins α<sub>M</sub>β<sub>2</sub> and α<sub>V</sub>β<sub>3</sub>
Rocco Romagnuolo, Corey A Scipione, Zainab A Bazzi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 23, 2013
Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone
Mathieu Garand, Joellen H H Lin, Branislava Zagorac, et al.
Clinical & Experimental Metastasis
|
January 27, 2017
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment
Zainab A Bazzi, Jennifer Balun, Dora Cavallo-Medved, et al.
Journal of Clinical Lipidology
|
September 21, 2024
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans
Daniel Bruwer, Zelda de Lange-Loots, Marlys L Koschinsky, et al.
The Journal of Biological Chemistry
|
April 17, 2003
Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
Mark A Hancock, Michael B Boffa, Santica M Marcovina, et al.
The Journal of Biological Chemistry
|
October 23, 2004
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9
Caroline H O'Neil, Michael B Boffa, Mark A Hancock, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
Thrombosis Research
|
July 11, 2018
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen on the surface of vascular endothelial and smooth muscle cells
Rocco Romagnuolo, Kristen DeMarco, Corey A Scipione, et al.
British Journal of Haematology
|
June 27, 2007
Molecular analysis of the human thrombin-activatable fibrinolysis inhibitor gene promoter
Mathieu Garand, Nazareth Bastajian, Michael E Nesheim, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 20, 2022
Apo(a) and ApoB Interact Noncovalently Within Hepatocytes: Implications for Regulation of Lp(a) Levels by Modulation of ApoB Secretion
Amer Youssef, Justin R Clark, Santica M Marcovina, et al.
Progress in Lipid Research
|
September 11, 2017
The renaissance of lipoprotein(a): Brave new world for preventive cardiology?
Katrina L Ellis, Michael B Boffa, Amirhossein Sahebkar, et al.
Atherosclerosis
|
June 1, 2018
Inhibition of pericellular plasminogen activation by apolipoprotein(a): Roles of urokinase plasminogen activator receptor and integrins α<sub>M</sub>β<sub>2</sub> and α<sub>V</sub>β<sub>3</sub>
Rocco Romagnuolo, Corey A Scipione, Zainab A Bazzi, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
February 23, 2013
Regulation of the gene encoding human thrombin-activatable fibrinolysis inhibitor by estrogen and progesterone
Mathieu Garand, Joellen H H Lin, Branislava Zagorac, et al.
Clinical & Experimental Metastasis
|
January 27, 2017
Activated thrombin-activatable fibrinolysis inhibitor attenuates the angiogenic potential of endothelial cells: potential relevance to the breast tumour microenvironment
Zainab A Bazzi, Jennifer Balun, Dora Cavallo-Medved, et al.
Journal of Clinical Lipidology
|
September 21, 2024
Fibrinogen and plasma clot properties are associated with apolipoprotein B and apolipoprotein B-containing lipoproteins in Africans
Daniel Bruwer, Zelda de Lange-Loots, Marlys L Koschinsky, et al.
The Journal of Biological Chemistry
|
April 17, 2003
Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
Mark A Hancock, Michael B Boffa, Santica M Marcovina, et al.
The Journal of Biological Chemistry
|
October 23, 2004
Stimulation of vascular smooth muscle cell proliferation and migration by apolipoprotein(a) is dependent on inhibition of transforming growth factor-beta activation and on the presence of kringle IV type 9
Caroline H O'Neil, Michael B Boffa, Mark A Hancock, et al.
Page
of 8